Formulary

A formulary is the list of prescription drugs that a particular health plan or prescription drug plan covers. HealthCare.gov defines it as "[a] list of prescription drugs covered by a prescription drug plan or another insurance plan offering prescription drug benefits," and carries a mirror entry titled "Drug list" with the same words. The two names are used interchangeably by the federal Marketplace itself, so a plan document that says "drug list" and a pharmacist who says "formulary" are describing the same document. What matters more than the name is whose list it is: a formulary belongs to the plan, not to medicine, so the fact that a drug is approved, prescribed and appropriate does not by itself make it covered.

The list is the coverage. For most benefits, a health plan decides what it pays by applying rules to a claim after the fact. For drugs it publishes the answer in advance, drug by drug, and that publication is the coverage decision. Two plans in the same market, at the same metal tier, with the same premium, can list different drugs for the same condition, because each built its own list. This is why comparing prescription coverage means comparing formularies rather than comparing plan summaries, and why the comparison has to be done by the specific drug name and dose rather than by the condition.

Tiers are the plan's design, and the plan must publish them. Most formularies sort covered drugs into levels, commonly a generic level, one or more brand levels, and a specialty level, with cost sharing rising as the tier rises. Federal rules for Marketplace plans do not prescribe the number of tiers or what belongs in each. What they require is disclosure: under 45 CFR 156.122(d)(1), a plan must publish an up-to-date, accurate and complete list of all covered drugs "including any tiering structure that it has adopted and any restrictions on the manner in which a drug can be obtained," in a form the public can reach, not only enrollees. So the tier structure is discoverable before enrollment, which is the only point in the year at which most people can act on it.

There is a floor on what the list must contain, and it is narrower than people assume. A plan providing essential health benefits must cover at least the greater of one drug in every United States Pharmacopeia category and class, or the same number of drugs in each category and class as the state's benchmark plan (45 CFR 156.122(a)(1)). "At least one drug in a class" is a real protection against a class being excluded outright, and it is not a promise that a particular drug within the class is covered. The same section requires the plan to submit its formulary to the Exchange, the state or the Office of Personnel Management.

A drug that is not on the list can still be covered, through a formulary exception. 45 CFR 156.122(c) requires a plan providing essential health benefits to run a process letting an enrollee, their designee or their prescriber request access to a clinically appropriate drug the plan does not otherwise cover. A standard request must be decided within 72 hours. An expedited request, available where the enrollee's life, health or ability to regain maximum function may be seriously jeopardized, or where they are already in a course of treatment on the drug, must be decided within 24 hours. A denial can be sent to an independent review organization on the same clocks. Two details make this worth knowing before it is needed: a granted standard exception covers the drug for the duration of the prescription, including refills, and the cost sharing on an excepted drug counts toward the plan's annual limitation on cost sharing, which is the out-of-pocket maximum.

Who builds the list. For Marketplace-style plans, 45 CFR 156.122(a)(3) requires the formulary to be developed and revised by a pharmacy and therapeutics committee, and sets standards for it: a majority of practicing physicians, pharmacists and other prescribers; at least 20 percent of members with no conflict of interest with the issuer or any drug manufacturer; meetings at least quarterly; written documentation of the rationale for every formulary decision; and, for plan years beginning on or after January 1, 2026, at least one patient representative. Medicare Part D carries its own committee requirement under a separate statute, so the two regimes reach the same structural idea by different routes.

A formulary changes, and the year you bought it is not the year you use it. Plans revise lists during a plan year as drugs are approved, as generics arrive, and as rebate arrangements move. A drug can be dropped, moved to a higher tier, or made subject to prior authorization or a quantity limit while a member is taking it. The practical protection is the exception process above, plus the annual opportunity to change plans, and the practical habit is to check the current formulary at each renewal rather than assuming last year's answer holds.

1. The plan builds a list of the drugs it will cover, subject to the minimum coverage floor and the committee process the rules require.

2. It sorts the list into tiers, and assigns a copayment or coinsurance level to each tier.

3. It publishes the list, including the tiering structure and any restrictions such as prior authorization, quantity limits or step therapy.

4. At the pharmacy the claim is priced by tier. A drug on a low tier is usually a fixed copayment; a specialty tier is often a percentage of the drug's price rather than a flat amount.

5. A drug that is not listed is generally not covered, and the money spent on it generally does not count toward the deductible or the out-of-pocket maximum. The route back to coverage is a formulary exception.

A hypothetical. Nadia's plan has four tiers: $10 for tier 1 generics, $45 for tier 2 preferred brands, $90 for tier 3 non-preferred brands, and 30% coinsurance for tier 4 specialty drugs. She fills a tier 1 generic monthly and pays $10 each time, or $120 over the year. Her second medication sits on tier 3 at $90 a month, or $1,080 over the year. In June her specialist adds a specialty drug with a plan price of $3,000 a month; at 30% she pays $900 a month for the seven remaining months of the year, or $6,300, unless her out-of-pocket maximum is reached first. Leaving that ceiling aside, her drug cost sharing for the year is $120 plus $1,080 plus $6,300, which is $7,500, and all of it came from decisions recorded in the formulary rather than from anything about the prescriptions themselves.

Pros

• The list is published in advance, so prescription coverage is one of the few parts of a health plan you can check before buying it.
• Tiering makes the cheaper clinical option cheaper for the patient too, which is the mechanism generics reach the counter through.
• A minimum coverage floor stops a plan excluding a whole class of drugs from its essential health benefits.
• A formulary exception process with federal deadlines exists for the drug that is not on the list, and a granted exception lasts for the prescription rather than one fill.

Cons

• The list belongs to the plan, so an appropriate prescription can still be an uncovered one.
• Covering "at least one drug in a class" says nothing about whether it is the drug that works for a particular person.
• A formulary can change mid-year, including moving a drug to a higher tier or adding prior authorization to it.
• Specialty tiers are often priced as a percentage rather than a flat copayment, which makes the member's cost move with the drug's price.
• Comparing plans properly means comparing formularies drug by drug, which is more work than comparing premiums and is the step most often skipped.